Literature DB >> 23448244

Loss-of-function mutation in AAGAB in Chinese families with punctuate palmoplantar keratoderma.

M Li1, L Yang, H Shi, B Guo, X Dai, Z Yao, G Zhang.   

Abstract

BACKGROUND: Punctate palmoplantar keratoderma (PPPK, OMIM 148600) is a rare hereditary disorder characterized by multiple punctate keratoses on the palms and soles. Recently, mutations in the genes α- and γ-adaptin-binding protein p34 (AAGAB) and collagen, type XIV, α1 (COL14A1) have been reported to cause PPPK.
OBJECTIVES: To identify mutations in the genes AAGAB and COL14A1 in three Chinese families with PPPK.
METHODS: Genomic DNA of the family members and 100 healthy individuals was isolated. Direct sequencing of all polymerase chain reaction products of the whole coding regions of AAGAB and COL14A1 was performed to identify the mutation.
RESULTS: A heterozygous nonsense mutation c.61C>T (p.Q21X) was identified in AAGAB in two Chinese families with PPPK. We failed to detect any mutations in AAGAB or COL14A1 in family 3.
CONCLUSIONS: A novel loss-of-function mutation within AAGAB associated with PPPK was identified from two Chinese pedigrees.
© 2013 The Authors BJD © 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448244     DOI: 10.1111/bjd.12289

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Identification of distinct mutations in AAGAB in families with type 1 punctate palmoplantar keratoderma.

Authors:  Megan Furniss; Claire A Higgins; Amalia Martinez-Mir; Liran Horev; Lynn Petukhova; Andrija Stanimirović; Jovan Miljković; Abraham Zlotogorski; Angela M Christiano
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

2.  New and recurrent AAGAB mutations in punctate palmoplantar keratoderma.

Authors:  E Pohler; M Huber; S E Boonen; M Zamiri; P A Gregersen; M Sommerlund; M Ramsing; D Hohl; W H I McLean; F J D Smith
Journal:  Br J Dermatol       Date:  2014-08-07       Impact factor: 9.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.